Baker McKenzie advises argenx on its strategic collaboration with Zai Lab in Greater China

Baker McKenzie has advised argenx on its strategic collaboration and exclusive license agreement with Zai Lab for the development and commercialization of efgartigimod in Greater China, including mainland China, Hong Kong, Taiwan and Macau.

Through this collaboration, argenx will be able to expand the reach of efgartigimod in Greater China, as well as accelerate the number of autoimmune indications in clinical development. Under the terms of the agreement, Zai Lab will recruit Chinese patients to argenx’s global registrational trials for the development of efgartigimod. This will allow argenx to accelerate efgartigimod development by initiating multiple phase 2 proof-of-concept trials in new autoimmune indications.

Baker McKenzie, which acted as lead counsel on the transaction, fielded a cross-office, cross-practice team led by Partners Koen Vanhaerents (Corporate Finance, Belgium); Denis Segota (Corporate & Securities, New York); and Oren Livne (Corporate & Securities, New York). They were supported by a team comprised of Partners Thomas Rice (Corporate & Securities, New York); Clement Ngai (IP, Shanghai); Roel Meers (Corporate Finance, Brussels); Luc Meeus (Corporate Finance, Brussels); Dorothea Koo (M&A/Private Equity, Hong Kong) and Tracy Wut (M&A/Private Equity, Hong Kong); and associate Julia Schieber (IP, Zurich – pictured).

Baker McKenzie advises argenx on its strategic collaboration with Zai Lab in Greater China

FabioAdmin

Legalcommunity.ch

Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website www.lcpublishinggroup.com

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2022 © All rights Reserved. Design by Origami Creative Studio

SHARE

Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram